Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Oncology (5)
402 Articles Available
5
17
Can't find what you're looking for? Try our
advanced search
.
Oncology
Tagrisso Significantly Improves Overall Survival in the Phase III FLAURA Trial for 1st-line EGFR-Mutated Non-Small Cell Lung Cancer
PR-M08-19-NI-041
Virtual Research
Boehringer Ingelheim and MD Anderson Form Unique Virtual Research and Development Center to Rapidly Advance New Cancer Therapies
PR-M08-19-NI-041
Oncology
Genentech’s Tecentriq® (ATEZOLIZUMAB) Reduced the Risk of Disease Worsening or Death in Advanced Bladder Cancer
PR-M08-19-NI-031
Clinical Data
Transgene Provides Update on PHOCUS Study of Pexa-Vec in Liver Cancer Following Planned Interim Futility Analysis
PR-M08-19-NI-015
Legal
Celgene to pay Mylan $62 Million to Resolve Cancer Drug Antitrust Case
PR-M08-19-NI-007
Engineered Bacteria
Tackling Solid Tumors with Engineered Bacteria
PAO-M08-19-NI-007
Oncology
Roche Receives CHMP Positive Opinion for New Tecentriq-based Combination Therapy as an Initial Treatment for Most Common Form of Advanced Lung Cancer
PR-M08-19-NI-004
FDA Approval
FDA Approves Bayer's Nubeqa® (darolutamide) for Prostate Cancer
PR-M08-19-NI-001
Oncology
New Approach to Treating Pancreatic Cancer Being Explored
PAO-M07-19-NI-023
Research
New Treatment Approach for Pancreatic Cancer
PAO-M07-19-NI-023
Drug Access
British Lung Cancer Patients Will Get Access to Pfizer’s Vizimpro
PAO-M07-19-NI-020
BLA
Astellas and Seattle Genetics Announce Submission of Biologics License Application to FDA for Enfortumab Vedotin
PR-M07-19-NI-050
M&A
AbbVie Enhances Early Stage Oncology Pipeline with Acquisition of Mavupharma
PR-M07-19-NI-038
Phase III
GSK Announces Positive Headline Results in Phase 3 PRIMA Study of ZEJULA (niraparib) For Patients with Ovarian Cancer
PR-M07-19-NI-039
Clinical Results
Positive Results for Colon Cancer Drug Drove Pfizer’s Purchase of Array BioPharma
PAO-M07-19-NI-017
Alliance
Nimbus Therapeutics and Celgene Expand Alliance to Immunotherapy in Oncology
PR-M07-19-NI-027
FDA Approval
FDA Grants Additional Myeloma Approval to J&J’s Darzalex
PAO-M07-19-NI-014
FDA Approval
Pfizer Receives U.S. FDA Approval for Its Oncology Biosimilar, ZIRABEV™ (bevacizumab-bvzr)
PR-M07-19-NI-015
Phase II
Iovance Biotherapeutics Provides Cervical Cancer Program Updates Following End of Phase 2 Meeting with U.S. Food and Drug Administration (FDA)
PR-M07-19-NI-016
Oncology
Imfinzi Improves Survival in the Phase III CASPIAN Trial in 1st-line Extensive-stage Small Cell Lung Cancer
PR-M07-19-NI-003
Biosimilar Approval
Herceptin Biosimilar Approved in the U.S.
PAO-M06-19-NI-017
FDA Approval
FDA Approves Pembrolizumab for Metastatic Small Cell Lung Cancer
PR-M06-19-NI-038
Immune Markers
Using Immune Markers to Identify Precancerous Cells
PAO-M06-19-NI-015
Leadership
Flatiron Health Appoints Cancer Researcher and Pharmaceutical Executive Dr. Michael Vasconcelles as Chief Medical Officer
PR-M06-19-NI-026
«
5
17
»
.svg)
